SCHEMBL6710364

SCHEMBL6710364

N#Cc1ccc(NC(=O)c2cc3cccc(NC(=O)Cc4cccs4)c3[nH]2)c(-c2nnn[nH]2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.42
MAPT P10636 3/20 0.42
POLB P06746 6/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
ALDH1A1 P00352 3/20 0.36
HTT P42858 2/20 0.36
NPC1 O15118 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
BLM P54132 2/20 0.36
THRB P10828 1/20 0.36
RECQL P46063 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TYMS P04818 1/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6708888 0.89 KDM4E (0.43) KDM4EMAPTPOLBMEN1KMT2A
SCHEMBL6712171 0.89 KDM4E (0.43) KDM4EMAPTPOLBMEN1KMT2A
SCHEMBL6709175 0.88 STK33 (0.40) KDM4EMAPTPOLBMEN1KMT2A
SCHEMBL6711927 0.88 PARP14 (0.44) MAPTPOLBTYMSPARP14
SCHEMBL6709018 0.87 PKM (0.35) MAPTPOLBTHRBTDP1PARP14
SCHEMBL6710352 0.87 MAPT (0.42) KDM4EMAPTPOLBMEN1KMT2A
SCHEMBL6713271 0.86 PARP14 (0.36) MAPTPOLBMEN1KMT2APARP14
SCHEMBL6711821 0.86 PARP14 (0.38) MAPTPARP14
SCHEMBL6916001 0.86 PARP14 (0.42) POLBMEN1KMT2ATYMSPARP14
SCHEMBL6708920 0.86 PARP14 (0.42) MAPTPOLBMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 KDM4E 1582/4885MAPT 4754/4885POLB 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.